HOME COMICS CHARACTERS TALK THINGS SITE

Comics : Venom: Finale

Note: Comics shown are for database purposes only. None of these comics are for sale. Valuations shown are indicative Near Mint Values. Dates shown are cover dates.

Section Name: Spider-Man Spin-Offs
Base Level: SM Spin-Off

#1
 Story: "The Spider Stratagem"
 Summary: Peter Parker Appears
Editor:  Tom Brevoort
Writer:  Larry Hama
Pencils:  Mark Pajarillo
Inker:  Robert Jones
Staff Only
Images
Review
Edit
Nov 1997 : NM ($2.00) : SM Guest
 Review by Joel Mathias (2 Webs)
#2
 Story: "Slaughter on Fifth Avenue"
 Summary: Spider-Man vs. Venom
Editor:  Tom Brevoort
Writer:  Larry Hama
Pencils:  Mark Pajarillo
Inker:  Robert Jones, Pam Eklund
Staff Only
Images
Review
Edit
Dec 1997 : NM ($2.00) : SM Guest
 Review by Joel Mathias (2 Webs)
#3
 Story: "What Counts in the End"
 Summary: Spider-Man vs. Venom
Editor:  Tom Brevoort
Writer:  Larry Hama
Pencils:  Mark Pajarillo
Inker:  Robert Jones
Staff Only
Images
Review
Edit
Jan 1998 : NM ($2.00) : SM Guest
 Review by Joel Mathias (2 Webs)
Edit/Add Entries for Venom: Finale
Create a New Title

Jump to the Spider-Man Comics Main Index.

The Spider-Man Comics Database is indexed in five different ways:

The Spider-Man Titles Index is categorized into:

If you're confused by the current titles, then you might want to read our:

That explains the current titles, and how they fit together.

If you can't find it here, then try:

  1. Peter Kroon's Spider-Man Covers Page
  2. Arthur's Marvel Comics Reprints Page
...or one of the other Comics Databases referenced on the Links Page.

Database Notes

For further information about the contents and arrangement of this database, please read our database notes page. This contains information on the inclusion guidelines, the graphics keys, the appearance levels, the comics/book values, the review ratings, and the SMURF codes.

This page is Un-Official. It is not associated with Marvel. It uses content copyright by Marvel, Without Permission. This material is used for the purposes of informed discussion, and is not intended to interfere with Marvel's right to use said material for their own commercial goals.